Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | METAP2 | P50579 | 2/20 | 0.53 |
| ▸ | METAP1 | P53582 | 1/20 | 0.53 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29593799 | 0.98 | ALDH1A1 (0.61) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| SCHEMBL29376732 | 0.98 | ALDH1A1 (0.61) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| SCHEMBL4268 | 0.98 | ALDH1A1 (0.61) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| Calcium SCHEMBL4962060 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| Water SCHEMBL8971546 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| Hydrochloric Acid SCHEMBL526822 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| Ammonia Solution, Strong SCHEMBL9297223 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| SCHEMBL4959080 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| SCHEMBL11769772 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD | |
| Bromide SCHEMBL7537985 | 0.96 | ALDH1A1 (0.59) | HSD17B10ALDH1A1KDM4EGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119280450-A | Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof | 孙国明 | 2025-01-10 | — | — | CN | claimed |
| CN-118844836-A | Long-acting disinfection and sterilization wet (towel) paper | 孙国明 | 2024-10-29 | — | — | CN | claimed |
| US-9421266-B2 | Safety of pseudoephedrine drug products | PISGAH LABORATORIES, INC. (US) | 2016-08-23 | — | — | US | claimed |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | PISGAH LABORATORIES, INC. | 2014-06-26 | — | — | US | claimed |
| US-8367693-B1 | Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties | PISGAH LABORATORIES, INC. (US) | 2013-02-05 | — | — | US | claimed |
| US-20090259039-A1 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance | PISGAH LABORATORIES, INC. | 2009-10-15 | — | — | US | claimed |
| US-20080293695-A1 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance | PISGAH LABORATORIES, INC. | 2008-11-27 | — | — | US | claimed |
| CN-119280450-A | Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof | 孙国明 | 2025-01-10 | — | — | CN | disclosed |
| CN-118844448-A | Preparation method of long-acting antibacterial liquid | 孙国明 | 2024-10-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293695-A1 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance | SLC6A2, SLC18A2, SLC6A3 | HSD17B10 2473/4885ALDH1A1 133/4885KDM4E 2701/4885 |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | SORD, ABCB11, ABCB1 | HSD17B10 2231/4885ALDH1A1 44/4885KDM4E 3611/4885 |
| US-20090259039-A1 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance | SLC18A2, SLC18A1, SLC6A2 | HSD17B10 2442/4885ALDH1A1 182/4885KDM4E 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.